Form 4 for CRTO Criteo S.A.
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0001576427-24-000113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | 2024-09-12 | CRTO | Damon Ryan | CLO | M - OptEx | $20.66 | +16.8K | 138.1K | +14% | +$348.0K |
| D | 2024-09-16 | 2024-09-12 | CRTO | Damon Ryan | CLO | S - Sale+OE | $44.37 | -16.8K | 121.2K | -12% | -$747.4K |
| D | 2024-09-16 | 2024-09-12 | CRTO | Damon Ryan | CLO | M - OptEx | $0.00 | -16.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-09-12 | M | A | 16,845 | $20.66 | 138,064 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. (F2) The exercise price of the stock option is 18.72 euros. The U.S. dollar equivalent of the exercise price is $20.66 using the exchange rate as of September 12, 2024 (1.00 = $1.1035). (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
| 2 | Common | Ordinary Shares | 2024-09-12 | S | D | 16,845 | $44.37 | 121,219 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. (F4) The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $44.24 to $44.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
| 3 | Derivative | Stock Option (right to buy) | 2024-09-12 | M | D | 16,845 | $0.00 | 0 | D | $20.66 · — to 2028-10-25 | 16,845 Ordinary Shares | (F2) The exercise price of the stock option is 18.72 euros. The U.S. dollar equivalent of the exercise price is $20.66 using the exchange rate as of September 12, 2024 (1.00 = $1.1035). (F5) Stock options granted on October 25, 2018. One-fourth of the grant vests on the first anniversary of the grant date and additional 1/16th of the grant vests quarterly thereafter for a period of 36 months, subject to continued service through each vesting date. |